Wang, K., Li, Z., Xuan, Y., Zhao, Y., Deng, C., Wang, M., . . . Mei, J. (2023). Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes. BMC.
Chicago-Zitierstil (17. Ausg.)Wang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
MLA-Zitierstil (9. Ausg.)Wang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.